Brief: Bellerophon Provides Clinical Program Update And Reports First Quarter 2023 Financial Results
15/05/2023 22:47
Bellerophon Therapeutics Inc BLPH.O :
* BELLEROPHON PROVIDES CLINICAL PROGRAM UPDATE AND REPORTS
FIRST
QUARTER 2023 FINANCIAL RESULTS
* BELLEROPHON THERAPEUTICS INC Q1 EARNINGS PER SHARE $0.27
* BELLEROPHON THERAPEUTICS INC: EXPECT TO REPORT TOP-LINE
RESULTS
FROM PHASE 3 REBUILD TRIAL IN MIDDLE OF THIS YEAR
* BELLEROPHON THERAPEUTICS INC: TOTAL LICENSING REVENUE FOR
THREE
MONTHS ENDED MARCH 31, 2023, WAS $5.6 MILLION
Source text for Eikon: ID:nGNX2RljWT
Further company coverage: BLPH.O
Recent news on Bellerophon Therapeutics
See all newsBrief: Bellerophon Therapeutics Inc On October 12, 2023, Board Of Directors Approved Plan Of Liquidation And Dissolution Of Company
Bellerophon Therapeutics Inc reports results for the quarter ended in June - Earnings Summary
Bellerophon Therapeutics Inc expected to post a loss of 42 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Archer-Daniels-Midland, Nucor, Copper miners
U.S. STOCKS ON THE MOVE-Hubbell, Spire Global, FibroGen